M. Na

SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer

Q. Shen, H. S. Kim, H. Yang, 2021, Oncogene.

HDAC6 Suppresses Let‐7i‐5p to Elicit TSP1/CD47‐Mediated Anti‐Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma

H. Wang, J. Eun, H. S. Kim, 2019, Hepatology.

Characteristic molecular signature of pericardial effusion identifies malignant cancer in pericardial disorder patients

J. Eun, H. S. Kim, H. Yang, 2019, Molecular & Cellular Toxicology.

The roles and mechanisms of coding and noncoding RNA variations in cancer.

Sang Yean Kim, Jin Woong Ha, Eunbi Shin, 2024, Experimental & molecular medicine.

Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma

J. Eun, H. Yang, Y. Ahn, 2022, Journal of clinical medicine.